FutureDx Summit 2026 · Next-Generation Sequencing Conference
Next-Generation Sequencing Conference 2026: FutureDx Summit, London
FutureDx Summit 2026 is a two-day next-generation sequencing conference in London, connecting 150+ NHS genomics, bioinformatics and molecular decision-makers with the companies building sequencing platforms and NGS diagnostics.
P.S. Part of the genomics field? See the wider genomics companies page.
We reply personally, usually within one working day.
FutureDx Summit is a UK next-generation sequencing (NGS) and genomics conference, held on 27–28 October 2026 in London, UK.
| Event | FutureDx Summit 2026 |
|---|---|
| Focus | Next-generation sequencing and molecular diagnostics |
| Dates | 27–28 October 2026 (two days) |
| Location | London, United Kingdom |
| Format | In-person conference, exhibition and pre-arranged 1:1 meetings |
| Who attends | 150+ NHS and industry diagnostics decision-makers |
| Organiser | FutureDx Summit |
Who should attend
- NHS Genomics Leadsgenomic medicine services
- Bioinformatics & Sequencing Leadsgenomics laboratories
- Clinical Scientistsmolecular and genomic diagnostics
- Laboratory Directorspathology and genomics services
- Infection & Surveillance Scientistspathogen genomics, UKHSA
- Sequencing & Genomics IndustryNGS platform and assay makers
Frequently asked questions
Is there a next-generation sequencing conference in the UK in 2026?
Yes. FutureDx Summit is a UK next-generation sequencing (NGS) conference held on 27–28 October 2026 in London. It covers clinical sequencing, pathogen genomics and NGS diagnostics for 150+ NHS and industry decision-makers.
What is next-generation sequencing (NGS)?
Next-generation sequencing (NGS) is high-throughput technology that reads DNA or RNA to identify pathogens, resistance markers and genetic variants. Clinical and pathogen sequencing is a core theme at FutureDx Summit 2026.
When and where is FutureDx Summit 2026?
FutureDx Summit 2026 takes place on 27–28 October 2026 in London, UK, as a two-day in-person conference.
Who should attend an NGS conference?
The programme suits NHS genomics leads, bioinformatics and sequencing specialists, clinical scientists, laboratory directors and pathogen-surveillance scientists, alongside the companies building sequencing platforms and NGS diagnostics.
At a glance
Where Sequencing Meets the NHS
A focused two-day summit in London, built around molecular and infectious disease diagnostics, with a drinks reception on Day 1.
Who it is for
Built for Sequencing and Genomics Companies
Wherever you sit in the sequencing stack, the NHS buyers who adopt it are in this room.
Sequencing Platform Makers
Short-read, long-read, and benchtop systems.
Library and Sample Prep
The chemistry that gets samples sequence-ready.
Bioinformatics and Analysis
Turning reads into a clinical answer.
Targeted Panels and Assays
Focused sequencing for routine questions.
Metagenomics and Pathogen Genomics
Sequencing built for infection.
Genomic Surveillance and Data
Population-scale monitoring and platforms.
The value
What Sequencing Unlocks
Sequencing is not a lab curiosity any more. In infection, it answers questions nothing else can, and these are the use cases NHS buyers are investing in.
Find the Unknown
Metagenomics identifies pathogens culture misses.
Pathogen Whole-Genome Sequencing
Strain-level detail for clinical and public health.
Detect Resistance Genes
AMR markers read straight from the sequence.
Track Outbreaks
Link cases and trace transmission.
Genomic Surveillance
Watch pathogens evolve across populations.
Targeted Panels
Focused sequencing for routine answers.
Why sponsor
Why Sequencing Companies Sponsor FutureDx
A platform only scales once labs adopt it. FutureDx puts you in front of the people who decide.
A Focused Room
Genomics and diagnostics buyers, not a general crowd.
Pre-Arranged Meetings
Confirmed time with the people who adopt platforms.
Validated Buyers
Decision-makers vetted before they register.
Measurable Return
A spend tied to meetings you can count and report.
The field
The Genomics the Room Covers
Sequencing sits within a wider genomics and molecular field. Explore the areas that match what you offer.
Genomics Companies
The broader genomics audience.
Explore genomics →Molecular Diagnostics
The wider molecular toolkit.
Explore molecular →Precision Medicine
Sequencing-led, targeted care.
Explore precision →Antimicrobial Resistance
Resistance genes from sequence.
Explore AMR →Clinical Genomics
Genomics in routine NHS practice.
Metagenomics
Sequencing everything in a sample.
Bioinformatics
The analysis and data layer.
Genomic Surveillance
Public health pathogen monitoring.
The room
Who You Will Meet
A sequencing platform scales only once the NHS adopts it. These are the people who decide.
Delegate Seniority
The Genomics Decision-Makers
Senior NHS genomics, laboratory, microbiology, and infection leaders, each validated before they register. The strongest fit is sequencing for infection and molecular diagnostics. Reach them through the 1:1 meetings programme or a sponsorship package.
Ways to take part
How to Sponsor, Exhibit, or Meet Buyers
Choose the level of presence that fits your goals. Every option includes pre-arranged meetings.
Sponsorship Packages →
From Gold to Headline, with branding, speaking, and meetings.
1:1 Meetings Programme →
Up to 20 pre-arranged meetings with validated buyers.
Exhibit →
A stand on a small, curated, senior floor.
Measure the ROI →
The framework to turn meetings into pipeline.
The pack
Get the Sponsor and Exhibitor Pack
Everything to Make the Call
- The full audience and seniority breakdown
- Sponsorship and exhibitor packages, side by side
- How the pre-arranged meeting model works
- Pricing and what is included at each level
- A simple ROI framework for your board
Sent by a person, with a conversation.
Questions
Next-Generation Sequencing Conference FAQs
Is FutureDx a next-generation sequencing conference?
Yes, with a focus. FutureDx is dedicated to infectious disease and molecular diagnostics, and sequencing is central to that through metagenomics, pathogen whole-genome sequencing, resistance gene detection, and genomic surveillance. It is the right room if your sequencing platform or service is adopted by NHS labs, and you will meet genomics, laboratory, and infection buyers rather than a pure research-sequencing audience.
When and where is it held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Who will we meet?
150 plus senior diagnostics professionals from across the UK, more than 60% at VP level and above, every one validated as a decision-maker or procurement influencer before they register, including genomics, laboratory, microbiology, and infection leaders.
How does NGS fit infectious disease diagnostics?
Closely. Metagenomic sequencing finds pathogens that culture misses, whole-genome sequencing gives strain-level detail, sequence data flags resistance genes, and genomic surveillance tracks outbreaks. These are exactly the use cases the NHS buyers in this room are investing in.
Why sponsor FutureDx as a sequencing company?
Because a sequencing platform only scales once labs adopt it, and that decision sits with NHS genomics and laboratory leaders. FutureDx puts you in pre-arranged meetings with exactly those buyers, with a return you can measure rather than a stand in a crowd.
What sponsorship and exhibitor options are available?
Options range from exhibiting to headline sponsorship, plus a standalone 1:1 Meetings programme. Each package includes a set number of pre-arranged meetings with validated buyers. Request the sponsor and exhibitor pack for the full breakdown and pricing.
How many meetings can we get?
It depends on your package: pre-arranged meetings range from 6 with Gold to 15 with Headline, or up to 20 with the standalone 1:1 Meetings programme. Each is a confirmed conversation with a validated NHS buyer.
It is the inaugural edition. Is it worth sponsoring?
The room is capped and validated, and your spend is tied to confirmed meetings rather than the gamble of footfall, which keeps it low-risk. Sponsoring the first edition also gives you first-mover visibility with the UK genomics and diagnostics community.
Take part
Put Your Sequencing Platform in Front of the NHS
Send your details and a senior member of the team replies with the sponsor and exhibitor pack and builds a plan around the genomics and lab buyers you most want to reach.
- Pre-arranged meetings with 150 plus validated buyers
- The NHS people who adopt sequencing
- A reply from a person, not an autoresponder
P.S. Want the wider field first? See genomics companies or molecular diagnostics.
Does FutureDx cover bioinformatics?
FutureDx Summit 2026 covers bioinformatics within its diagnostics programme, making it a bioinformatics diagnostics conference theme spanning sequencing analysis, pathogen genomics and data pipelines. London, 27–28 October 2026.